Retrospective cohort study of the efficacy and safety of dabigatran: real-life dabigatran use including very low-dose 75 mg twice daily administration

BACKGROUND: Dabigatran is a direct thrombin inhibitor and an anticoagulant that is prescribed to prevent ischemic stroke and systemic embolism in non-valvular atrial fibrillation. Dabigatran (150 mg twice daily) is non-inferior to warfarin for the prevention of stroke and systemic embolism. A dose r...

Descripción completa

Detalles Bibliográficos
Autores principales: Akagi, Yuuki, Chiba, Tatsuo, Uekusa, Shusuke, Kato, Hiroyoshi, Yamamura, Shigeo, Aoki, Yukiko, Enoki, Mizuho, Ogawara, Yuka, Kasahara, Takanori, Kimura, Yuki, Shimizu, Tadahiro, Takeishi, Aiko, Nakajima, Yuko, Kobayashi, Hideki, Sugi, Kaoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670142/
https://www.ncbi.nlm.nih.gov/pubmed/31388437
http://dx.doi.org/10.1186/s40780-019-0145-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670142/
https://www.ncbi.nlm.nih.gov/pubmed/31388437
http://dx.doi.org/10.1186/s40780-019-0145-3

Ejemplares similares